The FDA confirms that Sarepta nemesis Ronald Farkas has left the agency
The FDA’s Ronald Farkas was one of Sarepta’s toughest critics. When the biotech made a bid to win an accelerated approval for their Duchenne muscular …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
